Skip to main content
. 2007 Dec 17;153(4):710–720. doi: 10.1038/sj.bjp.0707631

Figure 1.

Figure 1

Potentiation of the effects of (−)-adrenaline by rolipram but not by cilostamide on left atrium. Representative experiments, depicting cumulative concentration–effect curves for (−)-adrenaline in the absence of PDE inhibitors (a), in the presence of rolipram (b) and in the presence of cilostamide (c). Black spots indicate −log(−)-adrenaline concentrations, achieved by cumulative administration. Ca, CaCl2 (9 mM); Iso, (−)-isoprenaline (200 μM).